Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia

Journal of Pharmaceutical Sciences

Volumn 102, Issue 5, 2013, Pages 1488-1494

  Gelfuso, Guilherme Martins ^a,b,c   Gratieri, Tais ^a,c   Delgado Charro, M Begoña ^b   Guy, Richard H ^b   Vianna Lopez, Renata Fonseca ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Bath   (United Kingdom)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Alopecia; Controlled delivery; Drug transport; Hair follicles; Iontophoresis; Minoxidil sulfate; Skin; Targeted drug delivery

Indexed keywords

ALCOHOL; MINOXIDIL SULFATE; WATER;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HAIR FOLLICLE; HAIR GROWTH; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; LIPOPHILICITY; MALE; NONHUMAN; PHYSICAL CHEMISTRY; SKIN PENETRATION; SKINFOLD THICKNESS; SWINE;

EID: 84876315852     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23485     Document Type: Article

References (41)

1. Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. 2004. Effect of minoxidil on profileration and apoptosis in dermal papilla cells of human hair follicle. J Derm Sci 34:91-98.
2. Shapiro J. 2003. Safety of topical minoxidil solution: A one-year, prospective, observational study. J Cutan Med Surg 7:322-329.
3. Kurbel S, Kurbel B, Zanić-Matanić D. 1999. Minoxidil and male-pattern alopecia: A potential role for a local regulator of sebum secretion with vasoconstrictive effects? Med Hypotheses 53:402-406.
4. Shorter K, Farjo NP, Picksley SM, Randall VA. 2008. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J 22:1725-1736.
5. Buhl AE, Waldon DJ, Baker CA, Johnson GA. 1990. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 95:553-557.
6. Gelfuso GM, Gratieri T, Simão PS, De Freitas LA, Lopez RF. 2011. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsul 28:650-658.
7. Bienová M, Kucerová R, Fiurásková M, Hajdúch M, Koláŕ Z. 2005. Androgenetic alopecia and current methods of treatment. Acta Dermatovenerol Alp Panonica Adriat 14:5-8.
8. Pharmcom website: Rogaine topical solution 5%. Accessed February 4th 2012, at: http://www.pharmcom.com/rogaine_data.html.
9. Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. 2009. Follicular transport route-Research progress and future perspectives. Eur J Pharm Biopharm 71:173-180.
10. Meidan VM, Bonner MC, Michniak BB. 2005. Transfollicular drug delivery-Is it a reality? Int J Pharm 306:1-14.
11. Wosicka H, Cal K. 2010. Targeting to the hair follicles: Current status and potential. J Dermatol Sci 57:83-89.
12. Souza JG, Gelfuso GM, Simão PS, Borges AC, Lopez RF. 2011. Iontophoretic transport of zinc phthalocyanine tetrasulfonic acid as a tool to improve drug topical delivery. Anticancer Drugs 22:783-793.
13. Grice JE, Ciotti S, Weiner N, Lockwood P, Cross SE, Roberts MS. 2010. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. J Pharm Sci 99:712-718.
14. Shim J, Seok Kang H, Park WS, Han SH, Kim J, Chang IS. 2004. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release 97:477-484.
15. Kalia YN, Naik A, Garrison J, Guy RH. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619-658.
16. Bath BD, Scott ER, Phipps JB, White HS. 2000. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin: Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles. J Pharm Sci 89:1537-1549.
17. Cullander C, Guy RH. 1991. Sites of iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode. J Invest Dermatol 97:55-64.
18. Turner NG, Guy RH. 1998. Visualization and quantitation of iontophoretic pathways using confocal microscopy. J Investig Dermatol Symp Proc 3:136-142.
19. Uitto OD, White HS. 2003. Electroosmotic pore transport in human skin. Pharm Res 20:646-652.
20. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709-2728.
21. Green PG, Hinz RS, Cullander C, Yamane G, Guy RH. 1991. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm Res 8:1113-1120.
22. Patzelt A, Richter H, Buettemeyer R, Huber HJ, Blume-Peytavi U, Sterry W, Lademann J. 2008. Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm 70:234-238.
23. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, Lademann J. 2005. Differential stripping: Determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 125:264-269.
24. Chiang P-C, Foster KA, Whittle MC, Su C-C, Pretzer DK. 2006. Medium throughput pKa determinations of drugs and chemicals by reverse phase HPLC with an organic gradient. J Liq Chromatogr Relat Technol 29:2291-2301.
25. Lademann J, Richter H, Meinke M, Sterry W, Patzelt A. 2010. Which skin model is the most appropriate for the investigation of topically applied substances into the hair follicles? Skin Pharmacol Physiol 23:47-52.
26. Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, Sterry W, Lademann J. 2007. Porcine ear skin: An in vitro model for human skin. Skin Res Technol 13:19-24.
27. Blume-Peytavi U, Massoudy L, Patzelt A, Lademann J, Dietz E, Rasulev U, Garcia Bartels N. 2010. Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur J Pharm Biopharm 76:450-453.
28. Marro D, Guy RH, Delgado-Charro MB. 2001. Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 70:213-7.
29. Djabri A, Guy RH, Delgado-Charro MB. 2012. Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy. Int J Pharm 435:76-82.
30. Leboulanger B, Guy RH, Delgado-Charro MB. 2004. Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci 22:427-433.
31. Merino V, López A, Kalia YN, Guy RH. 1999. Electrorepulsion versus electroosmosis: Effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res 16:758-761.
32. Lopez RF, Bentley MV, Delgado-Charro MB, Salomon D, Van den Bergh H, Lange N, Guy RH. 2003. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem Photobiol 77:304-308.
33. Tashiro Y, Shichibe S, Kato Y, Hayakawa E, Itoh K. 2001. Effect of lipophilicity on in vivo iontophoretic delivery. I. NSAIDs. Biol Pharm Bull 24:278-83.
34. Tashiro Y, Sami M, Shichibe S, Kato Y, Hayakawa E, Itoh K. 2001. Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers. Biol Pharm Bull 24:671-677.
35. Monteiro-Riviere NA, Inman AO, Riviere JE. 1994. Identification of the pathway of iontophoretic drug delivery: Light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 11:251-256.
36. Turner NG, Guy RH. 1997. Iontophoretic transport pathways: Dependence on penetrant physicochemical properties. J Pharm Sci 86:1385-1389.
37. Banga AK. 2011. Experimental methods and tools for transdermal delivery by physical enhancement methods. In Transdermal and intradermal delivery of therapeutic agents: Application of physical technologies; Banga AK Ed. Boca Raton, Florida: CRC Press, pp 27-51.
38. Netzlaff F, Schaefer UF, Lehr CM, Meiers P, Stahl J, Kietzmann M, Niedorf F. 2006. Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments. Altern Lab Anim 34:499-513.
39. Eller MG, Szpunar GJ, Della-Coletta AA. 1989. Absorption of minoxidil after topical application: Effect of frequency and site of application. Clin Pharmacol Ther 45:396-402.
40. Tamada JA, Comyns K. 2005. Effect of formulation factors on electroosmotic glucose transport through human skin in vivo. J Pharm Sci 94:1839-1849.
41. Mudry B, Carrupt PA, Guy RH, Delgado-Charro MB. 2007. Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Control Release 122:165-172.